Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody

Infection and Immunity

Volumn 65, Issue 4, 1997, Pages 1158-1164

  Zhang, Honglai ^a   Zhong, Zhaojing ^a   Pirofski, Liise Anne ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; POLYSACCHARIDE VACCINE; TETANUS TOXOID;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ARTICLE; BINDING AFFINITY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; ENZYME LINKED IMMUNOSORBENT ASSAY; MENINGITIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL;

EID: 0030962508     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.4.1158-1164.1997     Document Type: Article

References (39)

1. Adey, N. B., A. H. Mataragnon, J. E. Rider, J. M. Carter, and B. K. Kay. 1995. Characterization of phage that bind plastic from phage-displayed random peptide libraries. Gene 156:27-31.
2. Ahmed, R., and D. Gray. 1996. Immunological memory and protective immunity: understanding their relation. Science 272:54-60.
3. Azmi, F. H., A. H. Lucas, H. V. Raff, and D. M. Granoff. 1994. Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1. Infect. Immun. 62:1776-1786.
4. Bessen, L., J. Eason, A. Casadevall, and B. P. Currie. 1994. Characteristics at onset and clinical course of AIDS patients with cryptococcal meningitis, abstr. J18. In Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
5. Brummell, D. A., V. P. Sharma, N. N. Anand, D. Bilous, G. Dubuc, J. Michniewicz, C. R. MacKenzie, J. Sadowska, B. W. Sigurskjold, B. Sinnott, N. M. Young, D. R. Bundle, and S. A. Narang. 1993. Probing the combining site of an anti-carbohydrate antibody by saturation-mutagenesis: role of the heavy-chain CDR3 residues. Biochemistry 32:1180-1187.
6. Casadevall, A., M. DeShaw, M. Fan, F. Dromer, T. R. Kozel, and L. Pirofski. 1994. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan. Infect. Immun. 62:3864-3872.
7. Casadevall, A., and M. D. Scharff. 1995. Return to the past: the case for antibody-based therapies in infectious diseases. Clin. Infect. Dis. 21:150-161.
8. Cherniak, R., L. C. Morris, B. C. Anderson, and S. A. Meyer. 1991. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect. Immun. 59:59-64.
9. Currie, B. P., and A. Casadevall. 1994. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin. Infect. Dis. 19:1029-1033.
10. Cwirla, S. E., E. A. Peters, R. W. Barrett, and W. J. Dower. 1990. Peptides on phage: a vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. USA 87:6378-6382.
11. DeShaw, M., and L. Pirofski. 1995. Antibodies to Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan are ubiquitous in the serum of HIV+ and HIV- individuals. Clin. Exp. Immunol. 99:425-432.
12. Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387-395.
13. Devi, S. G. N., R. Schneerson, W. Egan, T. J. Ulrich, D. Bryla, J. B. Robbins, and J. E. Bennett. 1991. Cryptococcus neoformans serotype A glucuronoxy lomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect. Immun. 59:3700-3707.
14. Dromer, F., P. Aucouturier, J. Clauvel, G. Saimot, and P. Yeni. 1988. Cryptococcus neoformans antibody levels in patients with AIDS. Scand. J. Infect. Dis. 20:283-285.
15. Graybill, J. R. 1992. Cryptococcus neoformans. p. 1895-1899. In S. L. Gorbach, J. G. Bartlett, and N. R. Blacklow. (ed.). Infectious diseases. W. B. Saunders Company, Philadelphia, Pa.
16. Hoess, R. H., U. Brinkmann, T. Handel, and I. Pastan. 1993. Identification of a peptide which hinds to the carbohydrate-specific monoclonal antibody B3. Gene 128:43-49.
17. Houpt, D. C., T. Pfrommer, B. Young, T. A. Larson, and T. R. Kozel. 1994. Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan. Infect. Immun. 62:2857-2864.
18. Kooyman, D. L., S. B. McClellan, W. Parker, P. L. Avissar, M. A. Velardo, J. L. Platt, and J. S. Logan. 1996. Identification and characterization of a galactosyl peptide mimetic. Implications for use in removing xenoreactive antibodies. Transplantation 61:851-855.
19. Lucas, A. H., and D. M. Granoff. 1989. A major cross-reactive idiotype associated with human antibodies to the Haemophilus influenzae type b polysaccharide. J. Clin. Invest. 85:1158-1166.
20. Malipiero, U. V., N. S. Levy, and P. J. Gearhart. 1987. Somatic mutation in anti-phosphorylcholine antibodies. Immunol. Rev. 96:59-74.
21. McCafferty, J., A. D. Griffiths, G. Winter, and D. J. Chiswell. 1990. Phage antibodies: filamentous phage displaying antibody variable regions. Nature 348:552-554.
22. Mukherjee, J., A. Casadevall, and M. D. Scharff. 1993. Molecular characterization of the antibody responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J. Exp. Med. 177:1105-1116.
23. Mukherjee, J., L. Pirofski, M. D. Scharff, and A. Casadevall. 1993. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc. Natl. Acad. Sci. USA 90:3636-3640.
24. Mukherjee, J., M. D. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534-4541.
25. Mukherjee, S., S. C. Lee, and A. Casadevall. 1995. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages. Infect. Immun. 63:573-579.
26. Newman, B. A., and E. A. Kabat. 1985. An immunochemical study of the combining site specificities of C57BL/6J monoclonal antibodies to alpha (1-6)-linked dextran B512. J. Immunol. 135:1220-1231.
27. Oldenberg, D. R., D. Loganathan, I. J. Goldstein, P. G. Schultz, and M. A. Gallop. 1992. Peptide ligands for a sugar binding protein isolated from a random peptide library. Proc. Natl. Acad. Sci. USA 89:5393-5397.
28. Parmley, S. F., and G. P. Smith. 1988. Antibody-selectable filamentous fd phage vectors: affinity purification of target genes. Gene 73:305-318.
29. Pinilla, C., S. Chendra, and J. R. Appel. 1995. Elucidation of monoclonal antibody polyspecificity. Peptide Res. 8:250-257.
30. Pirofski, L., and A. Casadevall. 1996. Cryptococcus neoformans: paradigm for the role of antibody in immunity. Zentralbl. Bakteriol. 284:475-495.
31. Pirofski, L., R. Lui, M. DeShaw, A. B. Kressel, and Z. Zhong. 1995. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Infect. Immun. 63:3005-3014.
32. Scott, J. K., D. Loganathan, R. B. Easley, X. Gong, and I. J. Goldstein. 1992. A family of concanavalin A-binding peptides from a hexapeptide epitope library. Proc. Natl. Acad. Sci. USA 89:5398-5402.
33. Sikder, S. K., P. N. Akolkar, P. M. Kaladas, S. L. Morrison, and E. A. Kabat. 1985. Sequences of variable regions of hybridoma antibodies to alpha (1-6) dextran in BALB/c and C57BL/6 mice. J. Immunol. 135:4215-4221.
34. Sioud, M., A. Dybwad, L. Jespersen, S. Suleyman, J. B. Natvig, and O. Forre. 1994. Characterization of naturally occurring autoantibodies against tumour necrosis factor-alpha (TNF-alpha): in vitro function and precise epitope mapping by phage epitope library. Clin. Exp. Immunol. 98:520-525.
35. Sundstrom, J. B., and R. Cherniak. 1992. The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen. Infect. Immun. 60:4080-4087.
36. Valadon, P., G. Nussbaum, L. F. Boyd, D. H. Margulies, and M. D. Scharff. 1996. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. J. Mol. Biol. 261:11-22.
37. Westerink, M. A., P. C. Giardina, M. A. Apicella, and T. Kieber-Emmons. 1995. Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. Natl. Acad. Sci. USA 92:4021-4025.
38. Wilson, I. A., and R. L. Stanfield. 1995. A trojan horse with a sweet tooth. Struct. Biol. 2:433-436.
39. Zhong, Z., and L. Pirofski. 1996. Opsonization of Cryptococcus neoformans by human anti-glucuronoxylomannan antibodies. Infect. Immun. 64:3446-3450.